Skip to main content

Articles

Page 22 of 27

  9. Authors: Junfeng Zhang, Qindong Shi, Pengbo Yang, Xi Xu, Xinlin Chen, Cunfang Qi, Jianshui Zhang, Haixia Lu, Pengbo Zhang, Bingqiao Zhao, Ping Zheng and Yong Liu
    Citation: Molecular Neurodegeneration 2012 7(Suppl 1):S16
    Content type: Meeting abstract Published on:

    This article is part of a Supplement: Volume 7 Supplement 1

  14. Authors: Dehua Chui, Ting Zhou, Liang Zhou, Huan Yang, Xinying Liu, Tingting Liu, Jia Yu, Yi Liu, Xue Fei Wu, Hui Zhang and Dongsheng Fan
    Citation: Molecular Neurodegeneration 2012 7(Suppl 1):O9
    Content type: Oral presentation Published on:

    This article is part of a Supplement: Volume 7 Supplement 1

  24. NURR1 (also named as NR4A2) is a member of the steroid/thyroid hormone receptor family, which can bind to DNA and modulate expression of target genes. Previous studies have shown that NURR1 is essential for th...

    Authors: Xin Heng, Gang Jin, Xin Zhang, Dehuang Yang, Mingzhe Zhu, Shijun Fu, Xuping Li and Weidong Le
    Citation: Molecular Neurodegeneration 2012 7:4
    Content type: Research article Published on:

  25. We have followed-up on the recent genome-wide association (GWA) of the clusterin gene (CLU) with increased risk for Alzheimer disease (AD), by performing an unbiased resequencing of all CLU coding exons and regul...

    Authors: Karolien Bettens, Nathalie Brouwers, Sebastiaan Engelborghs, Jean-Charles Lambert, Ekaterina Rogaeva, Rik Vandenberghe, Nathalie Le Bastard, Florence Pasquier, Steven Vermeulen, Jasper Van Dongen, Maria Mattheijssens, Karin Peeters, Richard Mayeux, Peter St George-Hyslop, Philippe Amouyel, Peter P De Deyn…
    Citation: Molecular Neurodegeneration 2012 7:3
    Content type: Research article Published on:

  26. Dominantly inherited missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease, but its normal physiological function remains unclear. We previously re...

    Authors: Youren Tong, Emilie Giaime, Hiroo Yamaguchi, Takaharu Ichimura, Yumin Liu, Huiqing Si, Huaibin Cai, Joseph V Bonventre and Jie Shen
    Citation: Molecular Neurodegeneration 2012 7:2
    Content type: Research article Published on:

  27. The 5-lipoxygenase (5LO) enzymatic pathway is widely distributed within the central nervous system. Previous works showed that this protein is up-regulated in Alzheimer's disease (AD), and that its genetic abs...

    Authors: Jin Chu, Phillip F Giannopoulos, Carolina Ceballos-Diaz, Todd E Golde and Domenico Pratico
    Citation: Molecular Neurodegeneration 2012 7:1
    Content type: Research article Published on:

  28. The β-secretase, β-site amyloid precursor protein cleaving enzyme 1 (BACE1), is a prime therapeutic target for lowering cerebral β-amyloid (Aβ) levels in Alzheimer's disease (AD). Clinical development of BACE1...

    Authors: Tharinda W Rajapaksha, William A Eimer, Thomas C Bozza and Robert Vassar
    Citation: Molecular Neurodegeneration 2011 6:88
    Content type: Research article Published on:

  29. p23 belongs to the highly conserved p24 family of type I transmembrane proteins, which participate in the bidirectional protein transport between the endoplasmic reticulum and Golgi apparatus. Mammalian p23 ha...

    Authors: Ping Gong, Jelita Roseman, Celia G Fernandez, Kulandaivelu S Vetrivel, Vytautas P Bindokas, Lois A Zitzow, Satyabrata Kar, Angèle T Parent and Gopal Thinakaran
    Citation: Molecular Neurodegeneration 2011 6:87
    Content type: Research article Published on:

  30. Cerebral amyloid angiopathy (CAA) is characterized by deposition of fibrillar amyloid β (Aβ) within cerebral vessels. It is commonly seen in the elderly and almost universally present in patients with Alzheime...

    Authors: Byung Hee Han, Meng-liang Zhou, Ananth K Vellimana, Eric Milner, David H Kim, Jacob K Greenberg, Wenhua Chu, Robert H Mach and Gregory J Zipfel
    Citation: Molecular Neurodegeneration 2011 6:86
    Content type: Research article Published on:

  32. The p38α MAPK isoform is a well-established therapeutic target in peripheral inflammatory diseases, but the importance of this kinase in pathological microglial activation and detrimental inflammation in CNS d...

    Authors: Bin Xing, Adam D Bachstetter and Linda J Van Eldik
    Citation: Molecular Neurodegeneration 2011 6:84
    Content type: Research article Published on:

  33. Alpha synuclein (SNCA) has been linked to neurodegenerative diseases (synucleinopathies) that include Parkinson's disease (PD). Although the primary neurodegeneration in PD involves nigrostriatal dopaminergic ...

    Authors: Yofre Cabeza-Arvelaiz, Sheila M Fleming, Franziska Richter, Eliezer Masliah, Marie-Francoise Chesselet and Robert H Schiestl
    Citation: Molecular Neurodegeneration 2011 6:83
    Content type: Research article Published on:

  34. Detergent-insoluble protein accumulation and aggregation in the brain is one of the pathological hallmarks of neurodegenerative diseases. Here, we describe the identification of septin 11 (SEPT11), an enriched...

    Authors: Yair M Gozal, Nicholas T Seyfried, Marla Gearing, Jonathan D Glass, Craig J Heilman, Joanne Wuu, Duc M Duong, Dongmei Cheng, Qiangwei Xia, Howard D Rees, Jason J Fritz, Deborah S Cooper, Junmin Peng, Allan I Levey and James J Lah
    Citation: Molecular Neurodegeneration 2011 6:82
    Content type: Research article Published on:

  35. Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a polyglutamine expansion in the Huntingtin protein which results in the selective degeneration of striatal medium spiny neurons ...

    Authors: Xi Chen, Jun Wu, Svetlana Lvovskaya, Emily Herndon, Charlene Supnet and Ilya Bezprozvanny
    Citation: Molecular Neurodegeneration 2011 6:81
    Content type: Research article Published on:

  36. Atypical expression of cell cycle regulatory proteins has been implicated in Alzheimer's disease (AD), but the molecular mechanisms by which they induce neurodegeneration are not well understood. We examined t...

    Authors: Monique Judge, Lisa Hornbeck, Huntington Potter and Jaya Padmanabhan
    Citation: Molecular Neurodegeneration 2011 6:80
    Content type: Research article Published on:

  38. Fractalkine/CX3CL1 and its cognate receptor CX3CR1 are abundantly expressed in the CNS. Fractalkine is an unusual C-X3-C motif chemokine that is important in neuron-microglial communication, a co-receptor for HIV...

    Authors: Masami Suzuki, Nazira El-Hage, Shiping Zou, Yun-Kyung Hahn, Mary E Sorrell, Jamie L Sturgill, Daniel H Conrad, Pamela E Knapp and Kurt F Hauser
    Citation: Molecular Neurodegeneration 2011 6:78
    Content type: Research article Published on:

  40. Aggregatable amyloid β-peptide (Aβ) and non-aggregatable p3-Alcα are metabolic products of the γ-secretase cleavage of amyloid β-protein precursor (APP) and Alcadeinα (Alcα), respectively. Familial AD (FAD) -l...

    Authors: Tomoko Konno, Saori Hata, Yukiko Hamada, Yuko Horikoshi-Sakuraba, Tadashi Nakaya, Yuhki Saito, Tohru Yamamoto, Takayuki Yamamoto, Masahiro Maeda, Takeshi Ikeuchi, Sam Gandy, Hiroyasu Akatsu and Toshiharu Suzuki
    Citation: Molecular Neurodegeneration 2011 6:76
    Content type: Research article Published on:

  41. Mitochondria have roles or appear to have roles in the pathogenesis of several chronic age-related and acute neurological disorders, including Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, Parkin...

    Authors: Yi Wang, Yan Pan, Ann Price and Lee J Martin
    Citation: Molecular Neurodegeneration 2011 6:75
    Content type: Research article Published on:

  42. The 90-kDa ribosomal S6 kinase (Rsk) family is involved in cell survival. Rsk activation is regulated by sequential phosphorylations controlled by extracellular signal-regulated kinase (ERK) 1/2 and 3-phosphoi...

    Authors: Xavier Xifró, Marta Anglada-Huguet, Laura Rué, Ana Saavedra, Esther Pérez-Navarro and Jordi Alberch
    Citation: Molecular Neurodegeneration 2011 6:74
    Content type: Research article Published on:

  43. Abnormal distribution, modification and aggregation of transactivation response DNA-binding protein 43 (TDP-43) are the hallmarks of multiple neurodegenerative diseases, especially frontotemporal lobar degener...

    Authors: Ya-Fei Xu, Yong-Jie Zhang, Wen-Lang Lin, Xiangkun Cao, Caroline Stetler, Dennis W Dickson, Jada Lewis and Leonard Petrucelli
    Citation: Molecular Neurodegeneration 2011 6:73
    Content type: Research article Published on:

  44. Parkinson's disease (PD) is characterized by dopaminergic neurodegeneration in the substantia nigra (SN). Transforming growth factor-β1 (TGF-β1) levels increase in patients with PD, although the effects of thi...

    Authors: Silvia Tapia-González, Rosa M Giráldez-Pérez, M Isabel Cuartero, M José Casarejos, M Ángeles Mena, Xiao-Fan Wang and Amelia Sánchez-Capelo
    Citation: Molecular Neurodegeneration 2011 6:72
    Content type: Research article Published on:

  45. Brain-Derived Neurotrophic Factor (BDNF) is the main candidate for neuroprotective therapy for Huntington's disease (HD), but its conditional administration is one of its most challenging problems.

    Authors: Albert Giralt, Olga Carretón, Cristina Lao-Peregrin, Eduardo D Martín and Jordi Alberch
    Citation: Molecular Neurodegeneration 2011 6:71
    Content type: Research article Published on:

  46. APP expression misregulation can cause genetic Alzheimer's disease (AD). Recent evidences support the hypothesis that polymorphisms located in microRNA (miRNA) target sites could influence the risk of developi...

    Authors: Charlotte Delay, Frédéric Calon, Paul Mathews and Sébastien S Hébert
    Citation: Molecular Neurodegeneration 2011 6:70
    Content type: Short report Published on:

  47. We recently reported that expression levels of tumor necrosis factor (TNF) receptors, TNFR1 and TNFR2, are significantly changed in the brains and cerebrospinal fluid (CSF) with Alzheimer's disease (AD). Moreo...

    Authors: Hong Jiang, Harald Hampel, David Prvulovic, Anders Wallin, Kaj Blennow, Rena Li and Yong Shen
    Citation: Molecular Neurodegeneration 2011 6:69
    Content type: Research article Published on:

  48. Tissue plasminogen activator (tPA) exerts multiple functions in the central nervous system, depending on the partner with which it interacts. In particular, tPA acts as a positive neuromodulator of N-methyl-D-...

    Authors: Amandine Jullienne, Axel Montagne, Cyrille Orset, Flavie Lesept, David E Jane, Daniel T Monaghan, Eric Maubert, Denis Vivien and Carine Ali
    Citation: Molecular Neurodegeneration 2011 6:68
    Content type: Research article Published on:

  49. Recent studies suggest that the pathogenic process in neurodegenerative disorders may disrupt mature neuronal circuitries and neurogenesis in the adult brain. Abnormal activation of CDK5 is associated with neu...

    Authors: Leslie Crews, Rebecca Ruf, Christina Patrick, Wilmar Dumaop, Margarita Trejo-Morales, Cristian L Achim, Edward Rockenstein and Eliezer Masliah
    Citation: Molecular Neurodegeneration 2011 6:67
    Content type: Research article Published on:

  50. Parkinson's disease (PD) is a complex disorder caused by genetic, environmental and age-related factors, and it is more prevalent in men. We aimed to identify differentially expressed genes in peripheral blood...

    Authors: Merav Kedmi, Anat Bar-Shira, Tanya Gurevich, Nir Giladi and Avi Orr-Urtreger
    Citation: Molecular Neurodegeneration 2011 6:66
    Content type: Research article Published on:
Submit manuscript

Follow

  • ISSN: 1750-1326 (electronic)

Molecular Neurodegeneration

ISSN: 1750-1326